Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Gregory J. Kato, MD
Researcher Executive Director
1020 First Avenue
CSL Behring
King of Prussia, Pennsylvania, United States
Dr. Kato is a hematologist with an active translational research interest in sickle cell disease, especially disorders of the blood vessel wall that may contribute to pulmonary hypertension. He takes care of adults with sickle cell disease, and leads clinical and laboratory bench research to learn the causes of pulmonary hypertension and other forms of vascular dysfunction and to develop new treatments to improve or prevent it.
Dr. Kato’s research specialties have been in blood flow physiology studies, clinical trials and proteomic analysis of plasma to unravel new mechanisms contributing to complications of sickle cell disease and to the development of red blood cells in the bone marrow. He and his team have formulated a model to suggest that pulmonary hypertension, stroke, leg ulcers and priapism share features of vasculopathy and more severe hemolytic anemia, and that pain crisis, acute chest syndrome and avascular necrosis share evidence of poor blood circulation due to viscosity. These two groups overlap and are not completely distinct.
+myBinderRelated Content
-
10th Annual Sickle Cell Disease Therapeutics Conference – VirtualThe Annual Sickle Cell Disease Therapeut...
-
Teens with Sickle Cell Disease Moving from Pediatric Care to Adult CareMoving from pediatric (children’s) car...
-
High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after trans...BACKGROUND: Chronic blood transfusion is...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
-
Julie A. Panepinto, MD, MSPHJulie Panepinto is the Director of the D...
-
Texas Children’s HospitalThe Sickle Cell Center at Texas Children...
-
Ron Brathwaite, MDDr. Brathwaite graduated from the Univer...
